Methods of reducing risk of preterm birth
US11154562B2 · kind B2 · utility
2Cited by
18References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2019 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | Sep 24, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.